Puhlmann Markus 4
4 · Perspective Therapeutics, Inc. · Filed Dec 19, 2023
Insider Transaction Report
Form 4
Puhlmann Markus
Chief Medical Officer
Transactions
- Purchase
Common Stock
2023-12-15$0.27/sh+135,006$36,276→ 635,006 total - Purchase
Common Stock
2023-12-18$0.26/sh+60,419$15,461→ 695,425 total - Purchase
Common Stock
2023-12-19$0.34/sh+400,000$137,000→ 1,095,425 total